Logo image of ACHC

ACADIA HEALTHCARE CO INC (ACHC) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:ACHC - US00404A1097 - Common Stock

17.2 USD
+0.05 (+0.29%)
Last: 11/28/2025, 8:11:32 PM
17.2 USD
0 (0%)
After Hours: 11/28/2025, 8:11:32 PM
Buy % Consensus

79

ChartMill assigns a Buy % Consensus number of 79% to ACHC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 26.56. This target is 54.4% above the current price.
ACHC was analyzed by 20 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about ACHC.
In the previous month the buy percentage consensus was at a similar level.
ACHC was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
ACHC Historical Analyst RatingsACHC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -107 -97 -87 -77 -67 -57 -47 -37 -27 -17 -7 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 17.2017.1725.5026.5636.75 - -0.17% 48.26% 54.40% 113.66%
ACHC Current Analyst RatingACHC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-11-18 Keybanc Maintains Overweight -> Overweight
2025-11-12 RBC Capital Maintains Outperform -> Outperform
2025-11-10 Guggenheim Maintains Buy -> Buy
2025-11-07 Cantor Fitzgerald Maintains Neutral -> Neutral
2025-11-07 UBS Maintains Buy -> Buy
2025-11-06 Barclays Maintains Equal-Weight -> Equal-Weight
2025-10-08 Keybanc Maintains Overweight -> Overweight
2025-10-07 Cantor Fitzgerald Reiterate Neutral -> Neutral
2025-10-03 Raymond James Maintains Outperform -> Outperform
2025-09-10 B of A Securities Downgrade Buy -> Neutral
2025-08-14 Mizuho Maintains Neutral -> Neutral
2025-08-14 Raymond James Downgrade Strong Buy -> Outperform
2025-08-13 RBC Capital Maintains Outperform -> Outperform
2025-08-07 Guggenheim Maintains Buy -> Buy
2025-08-07 UBS Maintains Buy -> Buy
2025-08-07 Barclays Maintains Equal-Weight -> Equal-Weight
2025-05-14 Mizuho Maintains Neutral -> Neutral
2025-05-14 Keybanc Maintains Overweight -> Overweight
2025-05-14 Barclays Maintains Equal-Weight -> Equal-Weight
2025-04-09 Guggenheim Initiate Buy
2025-03-25 Mizuho Maintains Neutral -> Neutral
2025-03-03 Keybanc Maintains Overweight -> Overweight
2025-03-03 RBC Capital Maintains Outperform -> Outperform
2025-02-28 Barclays Downgrade Overweight -> Equal-Weight
2025-02-28 B of A Securities Maintains Buy -> Buy
2025-01-10 RBC Capital Reiterate Outperform -> Outperform
2025-01-07 TD Cowen Maintains Buy -> Buy
2025-01-07 Keybanc Upgrade Sector Weight -> Overweight
2024-12-12 Deutsche Bank Upgrade Hold -> Buy
2024-12-10 Cantor Fitzgerald Reiterate Neutral -> Neutral

ACADIA HEALTHCARE CO INC / ACHC FAQ

Can you provide the average price target for ACADIA HEALTHCARE CO INC stock?

20 analysts have analysed ACHC and the average price target is 26.56 USD. This implies a price increase of 54.4% is expected in the next year compared to the current price of 17.2.


How do analysts rate ACADIA HEALTHCARE CO INC (ACHC)?

The consensus rating for ACADIA HEALTHCARE CO INC (ACHC) is 79 / 100 . This indicates that analysts generally have a positive outlook on the stock.


Can you provide the analyst count for ACADIA HEALTHCARE CO INC stock?

The number of analysts covering ACADIA HEALTHCARE CO INC (ACHC) is 20.